Devanath B, Chetia B, Shakya A, Ghosh S, Patgiri S, Bhowmick I
3 Biotech. 2024; 14(12):301.
PMID: 39554985
PMC: 11568084.
DOI: 10.1007/s13205-024-04129-w.
Duffy S, Sleebs B, Avery V
Antimicrob Agents Chemother. 2024; 68(10):e0074624.
PMID: 39264187
PMC: 11459970.
DOI: 10.1128/aac.00746-24.
Hellingman A, Sifoniou K, Buser T, Thommen B, Walz A, Passecker A
ACS Infect Dis. 2024; 10(4):1286-1297.
PMID: 38556981
PMC: 11019541.
DOI: 10.1021/acsinfecdis.3c00707.
Lagnika H, Medjigbodo A, Djihinto O, Saizonou H, Mousse W, Akoton R
J Parasitol Res. 2024; 2024:9980715.
PMID: 38551013
PMC: 10977279.
DOI: 10.1155/2024/9980715.
Ding H, Dong Y, Deng Y, Xu Y, Liu Y, Wu J
Malar J. 2023; 22(1):181.
PMID: 37303047
PMC: 10257827.
DOI: 10.1186/s12936-023-04616-0.
Molecular docking and antimalarial evaluation of novel -(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as -DHFR inhibitors.
Adhikari N, Choudhury A, Shakya A, Ghosh S, Patgiri S, Singh U
3 Biotech. 2022; 12(12):347.
PMID: 36386564
PMC: 9649585.
DOI: 10.1007/s13205-022-03400-2.
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues.
Cortopassi W, Gunderson E, Annunciato Y, Silva A, Dos Santos Ferreira A, Teles C
Int J Parasitol Drugs Drug Resist. 2022; 20:121-128.
PMID: 36375339
PMC: 9771834.
DOI: 10.1016/j.ijpddr.2022.10.003.
Uncovering the antimalarial potential of toad venoms through a bioassay-guided fractionation process.
Wells M, Fossepre M, Hambye S, Surin M, Blankert B
Int J Parasitol Drugs Drug Resist. 2022; 20:97-107.
PMID: 36343571
PMC: 9772263.
DOI: 10.1016/j.ijpddr.2022.10.001.
Augmentation of photophysical features and Judd-Ofelt analysis of extensively green glowing terbium (III) complexes with nitrogen donor ancillary ligands.
Hooda P, Taxak V, Malik R, Khatri S, Phogat P, Khatkar S
Photochem Photobiol Sci. 2022; 21(11):2011-2034.
PMID: 35932374
DOI: 10.1007/s43630-022-00275-3.
Microwave synthesis and antimalarial screening of novel 4-amino benzoic acid (PABA)-substituted pyrimidine derivatives as dihydrofolate reductase inhibitors.
Choudhury A, Vinayagam S, Adhikari N, Ghosh S, Sattu K
3 Biotech. 2022; 12(8):170.
PMID: 35845109
PMC: 9279537.
DOI: 10.1007/s13205-022-03236-w.
Evaluation of antiplasmodial activity in silico and in vitro of N-acylhydrazone derivatives.
Oliveira F, Pinto A, Duarte C, Taranto A, Lorenzato Junior E, Cordeiro C
BMC Chem. 2022; 16(1):50.
PMID: 35810303
PMC: 9271247.
DOI: 10.1186/s13065-022-00843-9.
Plasmodium knowlesi: the game changer for malaria eradication.
Lee W, Cheong F, Amir A, Lai M, Tan J, Phang W
Malar J. 2022; 21(1):140.
PMID: 35505339
PMC: 9066973.
DOI: 10.1186/s12936-022-04131-8.
Growth, secondary metabolite production, and in vitro antiplasmodial activity of Sonchus arvensis L. callus under dolomite [CaMg(CO3)2] treatment.
Wahyuni D, Rahayu S, Zaidan A, Ekasari W, Prasongsuk S, Purnobasuki H
PLoS One. 2021; 16(8):e0254804.
PMID: 34415920
PMC: 8378700.
DOI: 10.1371/journal.pone.0254804.
Antiplasmodial activity of Ethanolic extract of Cassia spectabilis DC leaf and its inhibition effect in Heme detoxification.
Ekasari W, Basuki D, Arwati H, Wahyuni T
BMC Complement Med Ther. 2021; 21(1):71.
PMID: 33607987
PMC: 7896390.
DOI: 10.1186/s12906-021-03239-9.
Progress and challenges in the use of fluorescence-based flow cytometric assays for anti-malarial drug susceptibility tests.
Kulkeaw K
Malar J. 2021; 20(1):57.
PMID: 33478496
PMC: 7818911.
DOI: 10.1186/s12936-021-03591-8.
A simple monochromatic flow cytometric assay for assessment of intraerythrocytic development of Plasmodium falciparum.
Kulkeaw K, Ketprasit N, Tungtrongchitr A, Palasuwan D
Malar J. 2020; 19(1):74.
PMID: 32070344
PMC: 7027058.
DOI: 10.1186/s12936-020-03156-1.
Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
Singh J, Vijay S, Mansuri R, Rawal R, Kadian K, Sahoo G
PLoS One. 2019; 14(8):e0221032.
PMID: 31437171
PMC: 6705855.
DOI: 10.1371/journal.pone.0221032.
Drug susceptibility testing methods of antimalarial agents.
Maji A
Trop Parasitol. 2019; 8(2):70-76.
PMID: 30693210
PMC: 6329274.
DOI: 10.4103/2229-5070.248695.
Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Vivapain-3 (VP-3).
Saddala M, Adi P
Heliyon. 2018; 4(5):e00612.
PMID: 29756074
PMC: 5944417.
DOI: 10.1016/j.heliyon.2018.e00612.
Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.
Nsanzabana C, Djalle D, Guerin P, Menard D, Gonzalez I
Malar J. 2018; 17(1):75.
PMID: 29422048
PMC: 5806256.
DOI: 10.1186/s12936-018-2185-9.
